BrM-specific deletion at 11p15.5 (region harboring PRKCDBP) was also observed, and the chromosomal loss of this region is associated with BCBrM, with PRKCDBP identified as a putative tumor suppressor (53). The gene discussed is SMARCA2; the disease is neoplasm.